Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences (NQ: PACB )

9.430 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 9.430
Bid (Size) 9.200 (97)
Ask (Size) 9.970 (3)
Prev. Close 9.430
Today's Range 9.430 - 9.430
52wk Range 4.970 - 14.55
Shares Outstanding 247,079,374
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cathie Wood's Buying These 3 Stocks Hand Over Fist
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team. 
Via The Motley Fool
Analyst Expectations for Pacific Biosciences's Future
Via Benzinga

Performance

YTD
+18.77%
+18.77%
1 Month
-8.89%
-8.89%
3 Month
-25.34%
-25.34%
6 Month
+6.07%
+6.07%
1 Year
+61.75%
+61.75%

More News

Read More
Rising Fuel Costs Lead To Win For Energy, Cathie Wood's Biotech Play Loses Big - ETF Winners And Losers: Medium-Cap Returns
Via Benzinga
Topics ETFs
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Palantir Post Q2 Earnings Share Price Dip Doesn't Deter Cathie Wood — Ark Invest Buys $14M Worth Of Shares
Via Benzinga
The Latest Analyst Ratings for Pacific Biosciences
Via Benzinga
Analyst Ratings for Pacific Biosciences
Via Benzinga
Where Pacific Biosciences Stands With Analysts
Via Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
Via Benzinga
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
From GeneDx Holdings Corp.; PacBio
Via GlobeNewswire
Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter
Via Benzinga
Expert Ratings for Pacific Biosciences
Via Benzinga
Pacific Biosciences (NASDAQ: PACB) Making Surprising Moves in Friday Session
Via Investor Brand Network
Thoughts For Thursday: Back From The Holiday With Caution
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Via Benzinga
Market Mixes It Up With A Broad Rally
Via Talk Markets
Time To Play Small Cap Life Science Stocks
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
Via Benzinga
Something Happened In Biotech Last Week
Via Talk Markets
Cathie Wood Scoops Up AMD Stock On A Day When It Tanks Over 9%: Also Raises Stake In This Biotech Company
Via Benzinga
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
Via Talk Markets
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Rumble, TORM And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.